Company · CIK 0000914475 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
NEUROCRINE BIOSCIENCES INC · NBIX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 15, 5:03 pm EDT | David W. BoyerChief Corp. Affairs Officer | 826 | $157.45 | $130,051 | 8,722 | −8.65% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 15, 5:02 pm EDT | Matt AbernethyChief Financial Officer | 2,311 | $157.20 | $363,285 | 42,808 | −5.12% | 10b5-1 |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:07 pm EDT | Jude OnyiaChief Scientific Officer | 5,523 | $156.22 | $302,442 | 22,647 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:06 pm EDT | Darin LippoldtChief Legal Officer | 6,902 | $156.22 | $377,896 | 56,793 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:05 pm EDT | Sanjay Chandru KeswaniChief Medical Officer | 6,026 | $156.22 | $329,937 | 3,281 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:05 pm EDT | Kevin Charles GormanDirector | 22,182 | $156.22 | $1,224,609 | 517,797 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:05 pm EDT | Kyle GanoChief Executive Officer, Director | 12,497 | $156.22 | $684,244 | 154,728 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:04 pm EDT | Ingrid DelaetChief Regulatory Officer | 6,902 | $156.22 | $377,896 | 18,289 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:03 pm EDT | Julie CookeChief Human Resources Officer | 5,523 | $156.22 | $302,442 | 24,025 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:03 pm EDT | David W. BoyerChief Corp. Affairs Officer | 5,523 | $156.22 | $302,442 | 9,548 | — | 10b5-1 |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:02 pm EDT | Eric BenevichChief Commercial Officer | 9,661 | $156.22 | $528,961 | 67,297 | — | |
| Sep 11, 2026 AFForm 4 → | Sep 15, 5:02 pm EDT | Matt AbernethyChief Financial Officer | 7,729 | $156.22 | $423,200 | 45,119 | — | 10b5-1 |
| Sep 9, 2026 SForm 4 → | Sep 10, 8:29 pm EDT | Eric BenevichChief Commercial Officer | 2,154 | $154.61 | $333,030 | 64,408 | −3.24% | 10b5-1 |
| Sep 9, 2026 MForm 4 → | Sep 10, 8:29 pm EDT | Eric BenevichChief Commercial Officer | 3,194 | $43.24 | $138,109 | 66,562 | — | 10b5-1 |
| Sep 2, 2026 GForm 4 → | Sep 3, 9:39 pm EDT | Stephen A SherwinDirector | 1,000 | — | — | 14,860 | — | |
| Aug 4, 2026 GForm 4 → | Aug 5, 5:35 pm EDT | Jude OnyiaChief Scientific Officer | 2,409 | — | — | 20,996 | — | |
| Jul 29, 2026 MForm 4 → | Jul 30, 5:29 pm EDT | Leslie V NorwalkDirector | 842 | $139.43 | $117,400 | 2,430 | — | 10b5-1 |
| Jul 28, 2026 SForm 4 → | Jul 30, 5:29 pm EDT | Leslie V NorwalkDirector | 1,250 | $182.01 | $227,508 | 1,588 | −44.0% | 10b5-1 |
| Jul 10, 2026 SForm 4 → | Jul 13, 4:27 pm EDT | Ingrid DelaetChief Regulatory Officer | 4,367 | $181.02 | $790,514 | 16,225 | −21.2% | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 13, 4:27 pm EDT | Ingrid DelaetChief Regulatory Officer | 4,367 | $106.02 | $462,989 | 20,592 | — | 10b5-1 |
| Jul 9, 2026 SForm 4 → | Jul 13, 4:27 pm EDT | Darin LippoldtChief Legal Officer | 10,000 | $179.60 | $1,796,014 | 54,729 | −15.4% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 4:27 pm EDT | Darin LippoldtChief Legal Officer | 10,000 | $81.49 | $814,900 | 64,729 | — | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 9, 6:41 pm EDT | Ingrid DelaetChief Regulatory Officer | 14,571 | $178.65 | $2,603,112 | 16,225 | −47.3% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 9, 6:41 pm EDT | Ingrid DelaetChief Regulatory Officer | 14,571 | $103.52 | $1,508,390 | 24,658 | — | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 30, 4:52 pm EDT | Darin LippoldtChief Legal Officer | 10,000 | $170.15 | $1,701,492 | 54,729 | −15.4% | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 4:52 pm EDT | Darin LippoldtChief Legal Officer | 10,000 | $81.49 | $814,900 | 56,419 | — | 10b5-1 |
| Jun 5, 2026 SForm 4 → | Jun 9, 5:40 pm EDT | Stephen A SherwinDirector | 25,000 | $165.32 | $4,132,969 | 15,860 | −61.2% | 10b5-1 |
| Jun 5, 2026 MForm 4 → | Jun 9, 5:40 pm EDT | Stephen A SherwinDirector | 25,000 | $64.10 | $1,602,500 | 40,860 | — | 10b5-1 |
| Jun 5, 2026 GForm 4 → | Jun 9, 5:34 pm EDT | Jude OnyiaChief Scientific Officer | 2,441 | — | — | 23,405 | — | |
| Jun 4, 2026 SForm 4 → | Jun 8, 6:07 pm EDT | Leslie V NorwalkDirector | 1,250 | $168.06 | $210,072 | 2,838 | −30.6% | 10b5-1 |
| Jun 2, 2026 SForm 4 → | Jun 4, 6:02 pm EDT | Julie CookeChief Human Resources Officer | 36,937 | $156.22 | $5,770,235 | 22,374 | −62.3% | 10b5-1 |
| Jun 2, 2026 MForm 4 → | Jun 4, 6:02 pm EDT | Julie CookeChief Human Resources Officer | 24,965 | $81.49 | $2,034,398 | 59,311 | — | 10b5-1 |
| Jun 2, 2026 FMForm 4 → | Jun 4, 5:54 pm EDT | Sanjay Chandru KeswaniChief Medical Officer | 4,945 | $154.84 | $268,338 | 1,479 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 MForm 4 → | Sep 10, 8:29 pm EDT | Eric BenevichChief Commercial Officer | 3,194 | — | — | 0 | — | 10b5-1 |
| Jul 29, 2026 MForm 4 → | Jul 30, 5:29 pm EDT | Leslie V NorwalkDirector | 842 | — | — | 2,140 | — | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 13, 4:27 pm EDT | Ingrid DelaetChief Regulatory Officer | 4,367 | — | — | 0 | — | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 4:27 pm EDT | Darin LippoldtChief Legal Officer | 10,000 | — | — | 4,965 | — | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 9, 6:41 pm EDT | Ingrid DelaetChief Regulatory Officer | 14,571 | — | — | 7,478 | — | 10b5-1 |
| Jun 26, 2026 MForm 4 → | Jun 30, 4:52 pm EDT | Darin LippoldtChief Legal Officer | 10,000 | — | — | 14,965 | — | 10b5-1 |
| Jun 5, 2026 MForm 4 → | Jun 9, 5:40 pm EDT | Stephen A SherwinDirector | 25,000 | — | — | 0 | — | 10b5-1 |
| Jun 2, 2026 MForm 4 → | Jun 4, 6:02 pm EDT | Julie CookeChief Human Resources Officer | 24,965 | — | — | 0 | — | 10b5-1 |
| Jun 2, 2026 MForm 4 → | Jun 4, 5:54 pm EDT | Sanjay Chandru KeswaniChief Medical Officer | 3,212 | — | — | 9,634 | — |